×

Growth Opportunities

Emerging Growth Opportunities in the Global Magnetic Resonance Imaging (MRI) Sector

How are emerging clinical applications enhancing the value proposition and increasing market share in the MRI space? What strategies have top companies adopted to penetrate new verticals or regions? Which are the main tier I and tier II competitors? Find out more in this analysis.

Read more Request Info
Value-based Care and Acute Shortage of ICU Staff to Drive Virtual Critical Care Solutions

COVID-19 has created the demand for solutions that will cater to large patient populations remotely. This research highlights virtual care solutions for critical care applications, the current industry dynamics and future growth opportunities in the US & EU-5 landscape of this sector.

Read more Request Info
I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Segment

This analysis studies the evolution of the I-O segment from 2020 to 2025 and sheds light on the opportunities stakeholders can leverage to offer best-in-class solutions. Also, given the current scenario, learn why this segment is forecasted to reach $132.66 billion by 2025.

Read more Request Info

CxO Insights

The Future of Digital B2B Marketing—Beyond COVID-199

Shivaji Das
Managing Director - APAC & Partner

The importance of digital B2B marketing

Digital marketing is replacing traditional marketing. Digital ad spending accounted for nearly half of global ad marketing in 2019, with countries like China leading the digital-first approach. By 2023, the share of digital ad spending is forecast to be over 60%. While digital marketing is more dominant in the B2C space, the explosion of connected devices, increasing usage of personal smartphones for work, and the growing sophistication and cost-effectiveness of complementary technologies such as AR/VR, are also driving the shift to digital marketing in the B2B space. COVID-19 has accelerated this process, and the resulting cancellation of face-to-face meetings, industry events, seminars, etc., often leaves digital marketing as the only option. There has been a surge in virtual industry conferences and events, and social media campaigns targeting business buyers have increased manifold.

Schedule a consultation with an industry expert at no charge by contacting us at myfrost@frost.com. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.

Frost Radar & Top Growth Insights

Healthcare Cybersecurity

Frost Radar—US Healthcare Cybersecurity Market, 2020

Read more Request Info
In-vitro Diagnostics

COVID-19 Pandemic Catalyzes the Growth of In-vitro Diagnostics

Read more Request Info
Vision 20255

Vision 2025—What will Spur Disruptive Changes in Global Healthcare?

Read more Request Info
Consumer Wearables

Competitive Intensity and Growth for Global Consumer Wearables

Read more Request Info
Telehealth

Indian Telehealth Industry: Changing Paradigms and the Rise of Virtual Visits

Read more Request Info
Hospital Command Centers

Hospital Command Centers: Ongoing Resource Shortages Drive Growth

Read more Request Info
Digital Patient Engagement

Business Models Drive Growth for Digital Patient Engagement Solutions

Read more Request Info
Point-of-care Testing

Smartphone-based Solutions Steer Growth for Infectious Disease POCT

Read more Request Info

Analyst Insights

While the race to develop a safe and efficacious vaccine in a timely manner has been successful, lack of clarity on immunity duration, reinfection, transmission, demographics, among other factors, continue to impact uptake. As developed countries inoculate citizens with the COVID-19 vaccines, equitable access, stringent storage and distribution requirements remain the lynchpin of efforts behind large-scale immunization in low- and middle-income countries. Read on to learn Frost & Sullivan’s perspective.
Read more

Cashless societies will be the future. With COVID-19 increasing the use of digital payment services among consumers, service providers must leverage this momentum to retain users and transition them into the new “cashless” normal. Find out more here.
Read more

With one in six deaths due to cancer, it is the second-leading cause of death globally. Approximately 70% of deaths from cancer occur in low- and middle-income countries, according to the World Health Organization. Around three-quarters of cancer patients require hospitalization and one in six need re-hospitalization. Hospital admission can be of two types, planned (e.g. Scheduled chemotherapy) or unplanned (e.g. admission for nausea).
Read more

Press Releases

8 Global Shifts for 2021 Reshaping Industries, Governments and Society

2021 will mark the year of building resilience. As we learn to embrace uncertainty, the new year will bring about significant changes in the way we work and live. Changes in user behavior patterns will trigger major shifts in consumption and business models. Emerging advancements in technologies such as AI and automation will lead the way as we continue to fight the pandemic.

Read more

Command Center Solutions to Save Millions of Dollars for Hospitals by Addressing Operational Inefficiencies

Frost & Sullivan’s recent analysis, Critical Need for Efficiency amidst Ongoing Resource Shortages and Rising Demand Drive Global Hospital Command Centers Market, finds that hospital command centers are promising solutions to address operational inefficiencies faced by hospitals worldwide. Command centers have evolved into high-tech solutions with technologies such as data analytics, predictive analytics and digital twins.

Read more

Guardant Health AMEA Wins Frost & Sullivan’s Market Leadership Award for Liquid Biopsy in Precision Oncology in Asia, Middle East and Africa

Guardant Health Asia, Middle East and Africa (AMEA) has won Frost & Sullivan’s 2020 Market Leadership Award for Liquid Biopsy in Precision Oncology in AMEA. This accolade is a testament to the success of the company’s flagship liquid biopsy, the Guardant360® test, which oncologists are using to guide treatment decisions for advanced stage cancer patients.

Read more

What's New?

Growth Opportunity Briefings
  • Follow us  

Subscribe to the Health & Lifesciences Newsletter

Featured

Upcoming Events You Won't Want to Miss

Frost & Sullivan Institute

Click here to read more

Advertisement Queries

Click Here For More Info